Panacos Pharmaceuticals, Inc. (PANC)

Market Cap	54.00
Revenue (ttm)	99.00K
Net Income (ttm)	-35.76M
Shares Out	53.64M
EPS (ttm)	-0.67
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	15,423
Open	0.0000
Previous Close	0.0000
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0000
Beta	-17.14
RSI	48.13
Earnings Date	n/a

About Panacos Pharmaceuticals

Panacos Pharmaceuticals, Inc., a development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The company’s discovery technologies focus on novel targets in the virus life cycle, including virus maturation and virus fusion. Its product pipeline includes second- and third-generation programs in HIV maturation inhibition. The company was founded in 1999 and is headquartered in Watertown, Massachusetts.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 41
• Stock Exchange: OTCMKTS
• Ticker Symbol: PANC

Financial Performance

In 2007, Panacos Pharmaceuticals's revenue was $180,000, a decrease of -36.62% compared to the previous year's $284,000. Losses were -$37.46 million, -1.71% less than in 2006.